lyrica 75 mg
orifarm as - pregabalin - kapsel, hard - 75 mg
lyrica 150 mg
orifarm as - pregabalin - kapsel, hard - 150 mg
lyrica 150 mg
farmagon - pregabalin - kapsel, hard - 150 mg
lyrica 300 mg
farmagon - pregabalin - kapsel, hard - 300 mg
lyrica 20 mg/ ml
orifarm as - pregabalin - mikstur, oppløsning - 20 mg/ ml
neurontin 400 mg
farmagon - gabapentin - kapsel, hard - 400 mg
neurontin 300 mg
farmagon - gabapentin - kapsel, hard - 300 mg
xtandi
astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
empressin 20 ie/ ml
orpha-devel handels und vertriebs gmbh - argipressinmonoacetat - konsentrat til infusjonsvæske, oppløsning - 20 ie/ ml
mometason glenmark 1 mg/ g
glenmark arzneimittel gmbh - mometasonfuroat - krem - 1 mg/ g